CIS
BNTX icon

Capital International Sarl’s BioNTech BNTX Stock Holding History

Capital International Sarl’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,954
Closed -$2.09M – 277
2024
Q2 		$2.09M Buy
25,954
+1,896
+8% +$173K 0.06% 171
2024
Q1 		$2.22M Buy
24,058
+310
+1% +$29.7K 0.07% 180
2023
Q4 		$2.51M Buy
23,748
+1,437
+6% +$145K 0.09% 171
2023
Q3 		$2.42M Buy
22,311
+2,645
+13% +$293K 0.11% 159
2023
Q2 		$2.12M Buy
19,666
+3,776
+24% +$425K 0.1% 175
2023
Q1 		$1.98M Buy
15,890
+2,527
+19% +$347K 0.1% 179
2022
Q4 		$2.01M Buy
13,363
+2,460
+23% +$379K 0.14% 158
2022
Q3 		$1.47M Buy
+10,903
New +$1.67M 0.12% 166
2022
Q1 		– Sell
-5,688
Closed -$1.47M – 261
2021
Q4 		$1.47M Buy
5,688
+4,572
+410% +$1.25M 0.07% 208
2021
Q3 		$305K Sell
1,116
-491
-31% -$156K 0.03% 222
2021
Q2 		$360K Buy
+1,607
New +$303K 0.03% 220

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Sarl's BNTX Position: Q3 2024 in Review

Capital International Sarl sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 25,954 shares — an estimated $2.09M sold.

Capital International Sarl first reported a position in BNTX in Q2 2021 and held it in 11 quarters. The position peaked at $2.51M in Q4 2023. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Capital International Sarl reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Capital International Sarl sold 25,954 BioNTech shares in Q3 2024, an estimated $2.09M.
  • Capital International Sarl first reported a position in BioNTech in Q2 2021 and held it in 11 quarters.
  • Capital International Sarl's BioNTech position peaked at $2.51M in Q4 2023.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Capital International Sarl's 13F filing for Q3 2024, filed 13 Nov 2024.